Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
01530 3SBIO
RTNominal up6.100 +0.050 (+0.826%)
Others

02/05/2018 08:51

3SBio (01530) to collaborate with Refuge Biotechnologies

[ET Net News Agency, 2 May 2018] 3SBio Inc. (01530) said it entered into a research
collaboration with Menlo Park, California-based Refuge Biotechnologies, Inc., a company
leveraging gene engineering technologies to develop intelligent cell therapeutics
programmed to make decisions inside of patients.
The two companies will jointly design and carry out research programs focusing on
developing Programmed Therapeutic Cells that can produce therapeutic biologics agents in a
disease micro environment inside patient's body, using Refuge's platform technology. 3SBio
will have exclusive license to develop and commercialize the Programmed Therapeutic Cells
in Greater China under the research collaboration agreement. (HL)

Back to Others

Remark: Real time quote last updated: 26/04/2024 11:56
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2024 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.